Global Hypertension management devices market is expected to account to USD XX billion by 2027 expanding at a CAGR xx% in the forecast period of 2019 to 2027.
Hypertension was considered a burden from mainly of industrialized nations, largely due to complex genetic–environmental and social interactions. This may adversely affect both future cardiovascular events and mortality. While the disease burden continues to rise among industrialized nations, current trends also show a rapidly rising prevalence in developing nations.
Hypertension management device is the more effective and efficient way to manage the patients suffering from hypertension and other chronic disorders. Hypertension management devices is the great evolvement in healthcare compared to other conventional medicines and therapeutics available.
The report on the Global Hypertension Management Devices Market gives an estimation of the development of the market based on historical studies and also provides forecasts based on a comprehensive research. The report gives a complete market analysis for the forecast period from 2019 to 2027.
The market is divided into various segments with an in-depth outlook of the competitors and a listing of the profiled key players. Some of the major key players in the global market includes Medtronic Inc., Boston Scientific, Cordis, St. Jude Medical, Recor Medical. The market size in terms of revenue and volume is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
Hypertension Management Devices Market Dynamics
Currently, available hypertension management devices, with recent novel structures targeting the renal sympathetic nervous system offer the potential for a previously undertreated group of patients with resistant hypertension. Hypertension Management devices are used for many reasons like to cure illnesses and health conditions, to prevent or delay future health care problems, to reduce pain and increase quality of life, and sometimes merely to obtain information about their health status and prognosis.
Many of people with hypertension are undiagnosed, and of those diagnosed, around half are not taking antihypertensive medications, for this situation the hypertension management devices work better in treatment and cure. Hypertension management devices with emerging technologies might support improved detection and management of hypertension not only in the wider population but also within special population groups such as the elderly, pregnant women, and those with atrial fibrillation.
Global Hypertension Management Devices Market is segmented by device type, technology, End User and region.
By Device Type
● Renal Denervation Devices
● Carotid Sinus Stimulation Devices
The Renal Denervation Devices segment commands the hypertension management devices market & share the XX% of revenue in total market.
Renal denervation device is a promising contemporary evolution of a historical treatment for hypertension and aims to achieve a reduction in renal sympathetic activation. These devices have been shown to be important in both resistant hypertension and in other disease states including heart failure. Renal denervation device using catheter-based technology showed promise effects for treatment of resistant hypertension, with few undesirable side effects. Clinical research studies proved that RDD can prevent, reverse, or reduce the severity of hypertension, paving the way for human trials.
Currently, RDD that only commercially available device with randomized controlled trial evidence to support its clinical use in hypertension and cardiovascular disorders. The key players those are successful in launching the renal denervation devices are St Jude Medical, Boston Scientific, Covidien, ReCor Medical. The good safety profile given by the RDD is the major factor driving the global market during forecast period. Features like cost-effective analysis and the limited duration of patient follow-up is the key factors for the renal denervation devices segment to command the largest market share of XX% by 2027.
Despite the initial capital cost of the generator and the associated device and procedure costs, on a per-patient basis, RDN appears to be a highly cost-effective procedure. Numerous novel device technologies are under development, and existing catheter systems in hypertension management devices continue to be improved, which help to grow the global market during forecast period.
● Radiofrequency Ablation
Radiofrequency ablation (RFA) is thought to decrease both the afferent sympathetic signals from the kidney to the brain and the efferent signals from the brain to the kidney. The procedure decreases sympathetic activation, decreases vasoconstriction, and decreases activation of the renin-angiotensin system, which helps to release the stress of patients suffering from hypertension.
Radiofrequency ablation (RFA) is a new buzz in the treatment of hypertension and interventional cardiology. Recent advances in RFA have allowed transvascular techniques that are minimally invasive and can be delivered expeditiously and safely. Radio frequency ablation technology shows time-dependent interventions during treatment procedure and examine approaches used in humans and in the many experimental models that offer a better understanding of the role of sympathetic activity in cardiovascular disease.
Radiofrequency ablation energy sources are currently the preferred modalities and hence this technique under intense investigation. The results by RFA have been encouraging and offer promise for the future growth of the global market.
This technology focus on methods and techniques addressing sympathetic renal denervation in patients with drug-resistant hypertension, which in turn drive the global market during forecast period by 2027.
● Ambulatory care Settings
● Home Care
Physicians treat chronic diseases and hypertension almost exclusively in ambulatory care settings.
From the analysis of national data of hospitalizations, it seems that hypertension is listed as a primary diagnosis for 301 000 admissions and secondary diagnosis for 9 003 000 hospitalized patients, this created the need for hypertension management devices in hospitals and in ambulatory care centers. The use of hypertension management devices in long-term control and treatment, shows results in prevention of cardiovascular complications; controlling BP in patients hospitalized for reasons other than hypertension.
Improved detection and treatment of hypertension in ambulatory care settings would reduce a preventable burden of cardiac, cerebrovascular (ischemic and haemorrhagic stroke) and renal disease related to hypertension. The use of hypertension management devices as a primary care in hospitals creates the scope for growth of the global market during forecast period. The standard guidelines for prevention, screening, diagnosis and management & monitoring in cardiovascular and central nervous system related disorders from the healthcare sector, is expected to grow the ambulatory care settings segment globally.
● North America
● MEA & Africa
● Latin America
Hypertension is a widely prevalent condition, which is estimated to affect approximately 30% of the population in the United States. Hence, North America is expected to command largest market share of XX% by 227.
Comparative examination of hypertension management devices and analysis of their working structure by health care professionals from North America drive the global market during forecast period. Appropriate health care facility utilization by patients and high quality, inexpensive services given by doctors and physicians are helping to drive the global hypertension management devices market from this region substancially.
Focus on future health care needs, health care expenditure, and increased personnel training for handling hypertension management devices, helps to increase the level of treatment standardization in this region. New and emerging technologies in hypertension management devices have changed patterns of care and moving towards user-friendly devices, as a result, the region is dominant in the global market growth.
Public and Private organizations have made great strides in identifying causes of disease and disability, discovering treatments and cures, and working with practitioners to educate the public about how to reduce the incidence of hypertension and prevalence of major diseases and the functional limitations and discomfort they may cause. As a result hypertension management devices have major contribution in hospitalization from developed, developing and underdeveloped countries.
Key Players Operating in the Global Hypertension Management Devices Market
● Medtronic Inc.
● Boston Scientific
● St. Jude Medical
● Recor Medical
● Mercator Medsystems
● Kona Medical
● Ablative Solutions Inc.
This Report Is Submitted By : Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your
demand. This report can be personalized to meet your requirements. Get in
touch with us and our sales team will guarantee provide you to get a report that
suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high
growth emerging opportunities & technologies as well as threats to the
companies across the Healthcare, Pharmaceuticals, Electronics &
Communications, Internet of Things, Food and Beverages, Aerospace and
Defense and other manufacturing sectors.